Home | About IJMPO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Indian Journal of Medical and Paediatric Oncology
Search Article 
Advanced search 

    Article Cited by others


Comparison of the efficacy and safety of Rituximab (Mabthera™) and its biosimilar (Reditux™) in diffuse large B-cell lymphoma patients treated with chemo-immunotherapy: A retrospective analysis

Roy Partha Sarathi, John Shiji, Karankal Sadashiv, Kannan Sadhana, Pawaskar Preeti, Gawande Jayanta, Bagal Bhausaheb, Khattry Navin, Sengar Manju, Menon Hari, Gujral Sumeet, Nair Reena

Year : 2013| Volume: 34| Issue : 4 | Page no: 292-298

   This article has been cited by
1 Biosimilar medicines Review
Camila dos Reis,Ricardo Teixo,Fernando Mendes,Rui Santos Cruz
International Journal of Risk & Safety in Medicine. 2016; 28(1): 45
[Pubmed]  [Google Scholar] [DOI]
2 Efficacy and safety of a biosimilar rituximab in biologic nave patients with active rheumatoid arthritis
Kuttipurath Kandi Roshique,Vinod Ravindran
Clinical Rheumatology. 2015; 34(7): 1289
[Pubmed]  [Google Scholar] [DOI]


Read this article